Teicoplanin in therapeutic drug monitoring
Recent years have seen the emergence of teicoplanin usage for staphylococcal infections, in particular endocarditis, osteomyelitis, septic arthritis, and methicillin-resistant Staphylococcus aureus (MRSA). Teicoplanin is now routinely used as an alternative to vancomycin, due to its safety profile and ease of administration. This article discusses the advantages for teicoplanin, the need for routine monitoring, and […]
